Andromeda Biotech Ltd.
Records under this name other than patents Andromeda Biotech Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Andromeda Biotech Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,828,922 | HSP therapy in conjunction with a low antigenicity diet Formerly held Lapsed on the fee record Ended Sep 9, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2018 | USPTO record |
| US 7,576,177 | HSP Peptides and Analogs for Modulation of Immune Responses via Antigen Presenting Cells Lapsed on the fee record Ended Aug 18, 2017 · High confidence | Lapsed on the fee record | Ended Aug 18, 2017 | High confidence |